Related Experiment Video

Updated: Jan 8, 2026

Fecal micro RNA Isolation
05:35

Fecal micro RNA Isolation

Published on: October 28, 2020

5.3K

Unraveling the Significance of Fecal MicroRNA Profile in Alzheimer's Disease

Kavisha Katuwawala1,2, Prashant Bharadwaj1,2, Ian Martins1,2

  • 1Centre of Excellence for Alzheimer's Disease Research & Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, 6027, Australia.

Molecular Neurobiology
|December 21, 2025
PubMed

Insights

Fecal microRNAs and gut microbiota, influenced by diet, show promise for early Alzheimer's disease detection. This review explores their role as non-invasive indicators for intervention strategies.

Area of Science:

  • Neuroscience
  • Gastroenterology
  • Genetics

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder affecting millions worldwide.
  • Current treatments focus on symptom management; early detection is critical for intervention.
  • Fecal microRNA (miRNA) analysis offers a promising non-invasive diagnostic approach for AD.

Purpose of the Study:

  • To review the interplay between diet-modulated fecal miRNAs and gut microbiota in Alzheimer's disease.
  • To explore their potential as novel, non-invasive indicators for early AD detection and intervention.

Main Methods:

  • Literature review focusing on diet, gut microbiota, fecal miRNAs, and Alzheimer's disease.
  • Analysis of mechanisms linking dietary factors to gut microbiota composition and miRNA expression.
  • Examination of the gut-brain axis in the context of AD pathology.

Main Results:

  • Dietary components significantly influence gut microbiota and miRNA expression.
  • Specific miRNAs in fecal samples correlate with AD pathology and gut-brain axis function.
  • High-fat diets are associated with increased inflammation and AD risk.

Conclusions:

  • Diet-modulated fecal miRNAs and gut microbiota represent potential non-invasive biomarkers for early AD detection.
  • Understanding this interplay can inform novel intervention strategies for Alzheimer's disease.
  • Further research is warranted to validate these indicators for clinical application.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K